RecruitingPhase 2NCT06912763
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
Studying OBSOLETE: Lymphedema
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- M.D. Anderson Cancer Center
- Principal Investigator
- Clifton Fuller, MDM.D. Anderson Cancer Center
- Intervention
- Pravastatin (drug)(drug)
- Eligibility
- FEMALE
- Timeline
- 2025 – 2031
Study locations (1)
- MD Anderson Cancer Center, Houston, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06912763 on ClinicalTrials.govOther trials for OBSOLETE: Lymphedema
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNANCT06521268Effects of Inspiratory Muscle Training on LymphedemaBiruni University
- RECRUITINGNANCT05962827Testing for Increased Lipoproteins (a) [LP(a)] in Lymphedema Patients: Li-LYCentre Hospitalier Universitaire de Nice
- ACTIVE NOT RECRUITINGNANCT05682885The Effectiveness of Lymphatic Bypass SupermicrosurgeryDharmais National Cancer Center Hospital
- ACTIVE NOT RECRUITINGNANCT05441943Lymphaticovenous Anastomosis as Treatment for LymphedemaOdense University Hospital
- ACTIVE NOT RECRUITINGNANCT02384733Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated BoostDanish Breast Cancer Cooperative Group